TapewireFind a company

person · Reporting owner

BAKER G LEONARD JR

Disclosed activity across 1 company

Tapewire entity
44370
SEC CIK
0001201715

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CORCEPT THERAPEUTICS INCCORT · Entity 2620DirectorMay 21, 2026May 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CORCEPT THERAPEUTICS INC

Report date May 21, 2026 · Filed May 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right To Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.69 · Expires 2036-05-21Direct12,500 Reported balance After 2026-05-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-05-21 · Grant · Acquired 12,500 · Balance 12,500

F1: Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2026 Filed May 26, 2026 21:40 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GrantStock Option (Right To Buy) · Derivative 12,500 $0.00 Strike: $59.69 $0.00
Disclosure

SEC source: 0001201715-26-000010 · form4-05262026_090539.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2036-05-21

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 21:07 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 24,218 $33.56 $812,836.00
Disclosure

SEC source: 0001201715-26-000007 · form4-03192026_090326.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,146,631

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.44 to $33.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 21:07 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 75,782 $33.00 $2,500,972.72
Disclosure

SEC source: 0001201715-26-000007 · form4-03192026_090326.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,122,413

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $32.43 to $33.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $15.15 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 12

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2030-05-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 27, 2020 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 25,000 $0.00 Strike: $10.50 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 11

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2029-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 18, 2019 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 25,000 $0.00 Strike: $14.08 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 10

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2028-08-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 29, 2018 over a one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $12.13 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 9

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2027-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 24, 2017 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $5.86 $0.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · derivative · entry 8

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2026-07-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Exercisable ratably on each monthly anniversary of June 27, 2016 over one-year period.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $15.15 $454,500.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 5

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,095,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 25,000 $10.50 $262,500.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 4

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,065,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 25,000 $14.08 $352,000.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 3

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,040,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $12.13 $363,900.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 1,015,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 27, 2026 Filed Jan 29, 2026 21:10 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $5.86 $175,800.00
Disclosure

SEC source: 0001201715-26-000005 · form4-01292026_040101.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 985,262

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 23:11 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001201715-26-000003 · form4-01052026_110112.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
June 10, 2025 Filed Jun 13, 2025 00:08 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GrantStock Option (Right To Buy) · Derivative 15,000 $0.00 Strike: $72.27 $0.00
Disclosure

SEC source: 0001225208-25-005922 · doc4.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2035-06-10

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of June 10, 2025 over a one-year period, subject to the Reporting Person's continued service on each monthly venting date.

Read SEC document
January 01, 2025 Filed Jan 2, 2025 23:03 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001225208-25-000061 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
May 17, 2024 Filed May 21, 2024 22:25 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GrantStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $28.09 $0.00
Disclosure

SEC source: 0001225208-24-006289 · doc4.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2034-05-16

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 17, 2024 over a one-year period.

Read SEC document
July 17, 2023 Filed Jul 18, 2023 21:58 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-007580 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
May 19, 2023 Filed May 23, 2023 21:25 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GrantStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $24.10 $0.00
Disclosure

SEC source: 0001225208-23-006179 · doc4.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2033-05-18

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthy anniversary of May 19, 2023 over a one-year period.

Read SEC document
January 01, 2023 Filed Feb 13, 2024 21:46 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-003184 · doc5.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By limited partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
June 10, 2022 Filed Feb 14, 2023 23:40 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 207 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009387 · doc5.xml · nonDerivative · entry 3

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,046,631

F3 · kind: Represents the gift of shares from the Reporting Person's direct holdings to the trust described in footnote (4) for no consideration.

Read SEC document
June 10, 2022 Filed Feb 14, 2023 23:40 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 207 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009387 · doc5.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 955,262

F3 · kind: Represents the gift of shares from the Reporting Person's direct holdings to the trust described in footnote (4) for no consideration.

F4 · ownership.nature: Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Read SEC document
May 31, 2022 Filed Jun 2, 2022 21:11 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GrantStock Option (Right To Buy) · Derivative 20,000 $0.00 Strike: $20.84 $0.00
Disclosure

SEC source: 0001225208-22-007612 · doc4.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-05-30

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 31, 2022 over a one-year period.

Read SEC document
January 01, 2022 Filed Feb 14, 2023 23:40 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-009387 · doc5.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By limited partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 23:01 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 100,000 $21.53 $2,153,000.00
Disclosure

SEC source: 0001225208-21-009444 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,308,303

F3 · shares: These shares were previously held by the Reporting Person for the exclusive benefit of Sutter Hill Management Company, L.L.C. ("SHM"), pursuant to the policy of SHM, and the Reporting Person previously disclaimed beneficial ownership of such shares. For the purpose of Section 16, the purchase of these shares by Saunders Holdings, L.P. constituted a purchase by the Reporting Person to the extent that it increased his pecuniary interest in such shares.

F4 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 23:01 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 50,000 $21.53 $1,076,500.00
Disclosure

SEC source: 0001225208-21-009444 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,046,838

F1 · shares: These shares were previously held by the Reporting Person for the exclusive benefit of Sutter Hill Management Company, L.L.C. ("SHM"), pursuant to the policy of SHM, and the Reporting Person previously disclaimed beneficial ownership of such shares. For the purpose of Section 16, the purchase of these shares by the Reporting Person's Roth IRA constituted a purchase by the Reporting Person to the extent that it increased his pecuniary interest in such shares.

F2 · balance_after: The number of shares reported as directly held reflects the reduction of shares previously reported by the Reporting Person as held for the exclusive benefit of SHM, to the extent of the shares acquired by Saunders Holdings, L.P., as described in footnote.

Read SEC document
May 26, 2021 Filed May 28, 2021 22:24 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GrantStock Option (Right To Buy) · Derivative 20,000 $0.00 Strike: $21.45 $0.00
Disclosure

SEC source: 0001225208-21-008670 · doc4.xml · derivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2031-05-25

F1 · derivative.exercise_date: Exercisable ratably in equal installments on each monthly anniversary of May 26, 2021 over one-year period.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $6.55 $0.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 12

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2025-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F5 · derivative.exercise_date: Immediately exercisable.

F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $4.05 $0.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 11

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2022-06-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F5 · derivative.exercise_date: Immediately exercisable.

F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $4.42 $0.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 10

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2021-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F5 · derivative.exercise_date: Immediately exercisable.

F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 9

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2023-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F5 · derivative.exercise_date: Immediately exercisable.

F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionStock Option (Right To Buy) · Derivative 30,000 $0.00 Strike: $1.74 $0.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · derivative · entry 8

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,000 shares

Expires 2024-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F5 · derivative.exercise_date: Immediately exercisable.

F1 · derivative.underlying_shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F1 · ownership.direct: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $1.74 $52,200.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 5

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,146,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

F2 · ownership.direct: As described in footnote (1), includes an aggregate of 150,000 shares held for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of such shares.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $1.74 $52,200.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 4

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,116,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $4.05 $121,500.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 3

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,086,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $4.42 $132,600.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,056,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
May 18, 2021 Filed May 20, 2021 22:35 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 Exercise / conversionCommon Stock 30,000 $6.55 $196,500.00
Disclosure

SEC source: 0001225208-21-008372 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,026,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Pursuant to the policy of Sutter Hill Management Company, L.L.C. ("SHM"), the Reporting Person held these options and, following the exercise thereof, holds these shares for the exclusive benefit of SHM. The reporting person disclaims beneficial ownership of these securities.

Read SEC document
January 01, 2021 Filed Feb 15, 2022 01:12 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 GiftCommon Stock 0 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-009572 · doc5.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By limited partnership

Disclosed balance after: 3,308,303

F1 · kind: Represents gift of limited partnership interests in a limited partnership to other limited partners. The reporting person disclaims beneficial ownership of the shares held by the limited partnership except as to the reporting person's pecuniary interest therein.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
December 01, 2020 Filed Dec 3, 2020 00:41 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 68 $22.64 $1,539.52
Disclosure

SEC source: 0001225208-20-014182 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,208,303

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 30, 2020 Filed Dec 3, 2020 00:41 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 1,109 $22.80 $25,285.20
Disclosure

SEC source: 0001225208-20-014182 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,208,235

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.52 to $22.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 25, 2020 Filed Dec 1, 2020 00:46 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 361 $22.81 $8,232.79
Disclosure

SEC source: 0001225208-20-013993 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,207,126

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.60 to $22.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 24, 2020 Filed Nov 25, 2020 01:06 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 1,429 $22.93 $32,765.83
Disclosure

SEC source: 0001225208-20-013905 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,206,765

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.8163 to $23.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 23, 2020 Filed Nov 25, 2020 01:06 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 1,551 $22.93 $35,561.95
Disclosure

SEC source: 0001225208-20-013905 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,205,336

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.91 to $22.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 18, 2020 Filed Nov 20, 2020 00:48 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 2,372 $17.91 $42,490.58
Disclosure

SEC source: 0001225208-20-013700 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,203,785

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.75 to $17.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 17, 2020 Filed Nov 18, 2020 00:43 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 7,883 $17.82 $140,468.75
Disclosure

SEC source: 0001225208-20-013617 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,201,413

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.72 to $17.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F1 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 13, 2020 Filed Nov 18, 2020 00:43 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 200 $17.94 $3,588.00
Disclosure

SEC source: 0001225208-20-013617 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,193,530

F1 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 10, 2020 Filed Nov 12, 2020 23:07 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 15,000 $17.71 $265,635.00
Disclosure

SEC source: 0001225208-20-013478 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,193,330

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.47 to $17.94, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 09, 2020 Filed Nov 12, 2020 23:07 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 3,786 $17.96 $68,013.22
Disclosure

SEC source: 0001225208-20-013478 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,178,330

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.88 to $17.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
November 06, 2020 Filed Nov 11, 2020 01:21 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 13,500 $17.98 $242,665.20
Disclosure

SEC source: 0001225208-20-013344 · doc4.xml · nonDerivative · entry 1

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,174,544

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.90 to $17.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document
September 01, 2020 Filed Sep 2, 2020 00:26 UTC CORCEPT THERAPEUTICS INC CORT · Entity 2620 PurchaseCommon Stock 25,807 $12.50 $322,525.56
Disclosure

SEC source: 0001225208-20-011150 · doc4.xml · nonDerivative · entry 2

BAKER G LEONARD JR · CIK 0001201715 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Ltd Partnership

Disclosed balance after: 3,161,044

F1 · kind: The purchases reported in this Form 4 were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the sales of shares by the reporting person, to the extent of the reporting person's pecuniary interest therein, at prices ranging from $15.76 to $15.7602, inclusive, on May 28, 2020. The reporting person has agreed to pay to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.45 to $12.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the general partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.